7-Bromo-1,3-dihydroimidazo[4,5-c]pyridin-2-one, 95.0%, 100mg

(4-Chloro-pyrimidin-2-yl)-methyl-amine, 95.0%, 10g

3-Chloro-4-(chloromethyl)pyridine hydrochloride, 98%, 1g

Gefitinib-based PROTAC 3, 10mg

6-Bromo-2-naphthaldehyde, 95.0%, 5g

Methyl 6-bromo-4-indolecarboxylate, 95.0%, 25g

Syringe filters Millex® Hydrophilic polytetrafluoroethylene (PTFE), 0,45 µm, 13 mm, Millex®-LCR, 100 Piece(s)

2-tert-butyl-6-methyl-1,4-dihydropyrimidin-4-one, 97%, 2.5g

3-AMINO-1,1-CYCLOBUTANEDIMETHANOL, 95.0%, 500mg

N-(3-Fluoro-4-methylphenyl)acetamide, 98%, 100mg

(E)-3-(3,5-DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENYL)ACRYLIC ACID, 95%, 250mg

2,3-Dichloro-6-methylaniline, 95.0%, 1g

[4-(methoxycarbonyl)thiophen-2-yl]boronic acid, 98%, 1g